CAR Therapy for CLL: What are the Challenges?

Por Davila, Marco L, Brentjens, Renier
Publicado em 2013

Biology and clinical application of CAR T Cells for B cell malignancies

Por Davila, Marco L, Sadelain, Michel
Publicado no Int J Hematol (2016)

CARs Move To the Fast Lane

Por Davila, Marco L, Papapetrou, Eirini P
Publicado em 2014

CAR models: next-generation CAR modifications for enhanced T-cell function

Por Abate-Daga, Daniel, Davila, Marco L
Publicado no Mol Ther Oncolytics (2016)

CD19-Targeted CAR T Cells as Novel Cancer Immunotherapy for Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia

Por Davila, Marco L., Brentjens, Renier J.
Publicado no Clin Adv Hematol Oncol (2016)

CD19-targeted T Cells for Hematologic Malignancies: Clinical Experience to Date

Por Davila, Marco L, Sauter, Craig, Brentjens, Renier
Publicado no Cancer J (2015)

Using gene therapy to manipulate the immune system in the fight against B cell leukemias

Por Bouhassira, Diana CG, Thompson, Joshua J, Davila, Marco L
Publicado no Expert Opin Biol Ther (2015)

Identification and utilization of arbitrary correlations in models of recombination signal sequences

Por Cowell, Lindsay G, Davila, Marco, Kepler, Thomas B, Kelsoe, Garnett
Publicado em 2002

CD19 CAR-Targeted T Cells Induce Long-Term Remission and B Cell Aplasia in an Immunocompetent Mouse Model of B Cell Acute Lymphoblastic Leukemia

Por Davila, Marco L., Kloss, Christopher C., Gunset, Gertrude, Sadelain, Michel
Publicado em 2013

How do CARs work?: Early insights from recent clinical studies targeting CD19

Por Davila, Marco L., Brentjens, Renier, Wang, Xiuyan, Rivière, Isabelle, Sadelain, Michel
Publicado em 2012

Prospective Estimation of Recombination Signal Efficiency and Identification of Functional Cryptic Signals in the Genome by Statistical Modeling

Por Cowell, Lindsay G., Davila, Marco, Yang, Kaiyong, Kepler, Thomas B., Kelsoe, Garnett
Publicado em 2003

Conserved cryptic recombination signals in Vκ gene segments are cleaved in small pre-B cells

Por Lieberman, Anne E, Kuraoka, Masayuki, Davila, Marco, Kelsoe, Garnett, Cowell, Lindsay G
Publicado em 2009

Multiple, conserved cryptic recombination signals in V(H) gene segments: detection of cleavage products only in pro–B cells

Por Davila, Marco, Liu, Feifei, Cowell, Lindsay G., Lieberman, Anne E., Heikamp, Emily, Patel, Anjali, Kelsoe, Garnett
Publicado em 2007

Chimeric antigen receptors for the adoptive T cell therapy of hematologic malignancies

Por Davila, Marco L., Bouhassira, Diana C. G., Park, Jae H., Curran, Kevin J., Smith, Eric L., Pegram, Hollie J., Brentjens, Renier
Publicado no Int J Hematol (2013)

IL-2 promotes early Treg reconstitution after allogeneic hematopoietic cell transplantation

Por Betts, Brian C., Pidala, Joseph, Kim, Jongphil, Mishra, Asmita, Nishihori, Taiga, Perez, Lia, Ochoa-Bayona, Jose Leonel, Khimani, Farhad, Walton, Kelly, Bookout, Ryan, Nieder, Michael, Khaira, Divis K., Davila, Marco, Alsina, Melissa, Field, Teresa, Ayala, Ernesto, Locke, Frederick L., Riches, Marcie, Kharfan-Dabaja, Mohamed, Fernandez, Hugo, Anasetti, Claudio
Publicado no Haematologica (2017)

CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia

Por Brentjens, Renier, Davila, Marco L, Riviere, Isabelle, Park, Jae, Wang, Xiuyan, Cowell, Lindsay G, Bartido, Shirley, Stefanski, Jolanta, Taylor, Clare, Olszewska, Malgorzata, Borquez-Ojeda, Oriana, Qu, Jinrong, Wasielewska, Teresa, He, Qing, Bernal, Yvette, Rijo, Ivelise V, Hedvat, Cyrus, Kobos, Rachel, Curran, Kevin, Steinherz, Peter, Jurcic, Joseph, Rosenblat, Todd, Maslak, Peter, Frattini, Mark, Sadelain, Michel
Publicado em 2013

Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias

Por Brentjens, Renier J., Rivière, Isabelle, Park, Jae H., Davila, Marco L., Wang, Xiuyan, Stefanski, Jolanta, Taylor, Clare, Yeh, Raymond, Bartido, Shirley, Borquez-Ojeda, Oriana, Olszewska, Malgorzata, Bernal, Yvette, Pegram, Hollie, Przybylowski, Mark, Hollyman, Daniel, Usachenko, Yelena, Pirraglia, Domenick, Hosey, James, Santos, Elmer, Halton, Elizabeth, Maslak, Peter, Scheinberg, David, Jurcic, Joseph, Heaney, Mark, Heller, Glenn, Frattini, Mark, Sadelain, Michel
Publicado em 2011

Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia

Por Davila, Marco L., Riviere, Isabelle, Wang, Xiuyan, Bartido, Shirley, Park, Jae, Curran, Kevin, Chung, Stephen S., Stefanski, Jolanta, Borquez-Ojeda, Oriana, Olszewska, Malgorzata, Qu, Jinrong, Wasielewska, Teresa, He, Qing, Fink, Mitsu, Shinglot, Himaly, Youssif, Maher, Satter, Mark, Wang, Yongzeng, Hosey, James, Quintanilla, Hilda, Halton, Elizabeth, Bernal, Yvette, Bouhassira, Diana C. G., Arcila, Maria E., Gonen, Mithat, Roboz, Gail J., Maslak, Peter, Douer, Dan, Frattini, Mark G., Giralt, Sergio, Sadelain, Michel, Brentjens, Renier
Publicado no Sci Transl Med (2014)

Donor CD19-CAR T Cells Exert Potent Graft-versus-Lymphoma Activity With Diminished Graft-versus-Host Activity

Por Ghosh, Arnab, Smith, Melody, James, Scott E., Davila, Marco L., Velardi, Enrico, Argyropoulos, Kimon V., Gunset, Gertrude, Perna, Fabiana, Kreines, Fabiana M., Levy, Emily R., Lieberman, Sophie, Jay, Hilary, Tuckett, Andrea Z., Zakrzewski, Johannes L., Tan, Lisa, Young, Lauren F., Takvorian, Kate, Dudakov, Jarrod A., Jenq, Robert R., Hanash, Alan M., Motta, Ana Carolina F., Murphy, George F., Liu, Chen, Schietinger, Andrea, Sadelain, Michel, van den Brink, Marcel R.M.
Publicado no Nat Med (2017)

Chiles en México

Publicado no D’Amérique latine (2021)